STAK Inc. Announces Closing of Initial Public Offering
CHANGZHOU, China, Feb. 28, 2025 /PRNewswire/ -- STAK Inc. (the "Company") (Nasdaq: STAK), a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment, today...
JULIEN'S AUCTIONS PRESENTS BOLD LUXURY: THE LIMELIGHT EDIT
Featuring Iconic Fashion from Marilyn Monroe, Elizabeth Taylor, Cher, Victoria Beckham, Amy Winehouse, Hermes, Chanel, Giambatista Valli & More A Landmark Sale of Fashion and Hollywood Iconography Live at The Peninsula Beverly Hills | March 27,...
EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements
PROVIDENCE, R.I., Feb. 27, 2025 /PRNewswire/ -- EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's immunoinformatics team in 2014 and spearheaded the development of a new...
Lichen China Limited Announces Effective Date of Reverse Stock Split and Name Change
XIAMEN, China, Feb. 27, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced the date of effectiveness and the ratio of a forthcoming...
Daqo New Energy Announces Unaudited Fourth Quarter and Fiscal Year 2024 Results
SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results...
Minesto publishes Year-End Report 2024
GOTHENBURG, Sweden, Feb. 27, 2025 /PRNewswire/ -- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and proprietary innovation." Significant events...
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1, a self-developed and...
U.S. Institute of Peace Announces Visaka Dharmadasa the Fifth Annual Women Building Peace Award Laureate
WASHINGTON, Feb. 27, 2025 /PRNewswire/ -- The U.S. Institute of Peace (USIP) is honored to announce Visaka Dharmadasa of Sri Lanka as the Fifth Annual Laureate of USIP's Women Building Peace Award. This international award, which is given annually,...
Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®
PERTH, Australia, Feb. 27, 2025 /PRNewswire/ -- Neopharma Technologies Ltd (Neopharma) is pleased to announce a strategic partnership with AusChain Pty Ltd, a global leader in scalable blockchain solutions specializing in product traceability...
Allianz Asia Pacific Celebrates the Inaugural Graduation of 200 Agents and Agency Leaders from the Pinnacle Excellence Program in Partnership with INSEAD
Setting a New Standard in Future-Proofing the Next Generation of Financial Advisors SINGAPORE, Feb. 27, 2025 /PRNewswire/ -- Allianz Asia Pacific proudly announces the inaugural graduation of 200 agents and agency leaders from its Pinnacle...